TY - JOUR AU - Shigematsu, Takashi AU - Muraoka, Ryoichi AU - Sugimoto, Toshitsugu AU - Nishizawa, Yoshiki PY - 2017 DA - 2017/02/15 TI - Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials JO - BMC Nephrology SP - 66 VL - 18 IS - 1 AB - The clinical effect of bisphosphonate treatment has not been clearly evaluated by kidney function in Japanese Chronic Kidney Disease (CKD) patients with osteoporosis. This study analyzed the data from three risedronate Japanese phase III trials. The clinical effect of risedronate therapy was evaluated in CKD patients with osteoporosis. SN - 1471-2369 UR - https://doi.org/10.1186/s12882-017-0478-9 DO - 10.1186/s12882-017-0478-9 ID - Shigematsu2017 ER -